Orchestra BioMed Holdings, Inc.
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
3.21 |
3.09 |
3.38 |
5.00 |
18.17 |
56.23 |
Przychód Δ r/r |
0.00% |
-3.87% |
9.70% |
47.75% |
263.38% |
209.45% |
Przychód (min) |
2.80 |
2.18 |
1.12 |
2.69 |
9.76 |
30.21 |
Przychód (max) |
3.39 |
4.02 |
5.00 |
6.85 |
24.89 |
77.01 |
EBITDA (średnia) |
-1.93 |
-1.85 |
-2.03 |
-3.00 |
-10.90 |
-33.74 |
EBIT (średnia) |
-1.93 |
-1.85 |
-2.03 |
-3.00 |
-10.90 |
-33.74 |
EBIT % |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
Zysk netto (średni) |
-61.03 |
-74.13 |
-66.73 |
-59.75 |
-45.66 |
-18.41 |
Zysk netto % |
-1901.58% |
-2402.67% |
-1971.45% |
-1194.79% |
-251.25% |
-32.74% |
EPS (średnia) |
-1.66 |
-2.01 |
-1.77 |
-1.62 |
-1.24 |
-0.50 |
Liczba analityków (Przychody) |
5 |
5 |
6 |
3 |
1 |
2 |
Liczba analityków (EPS) |
5 |
5 |
5 |
2 |
1 |
1 |
symbol |
OBIO |
OBIO |
OBIO |
OBIO |
OBIO |
OBIO |